If you, like me, have diabetes, you realize upon reflection that you are, despite the constant demands of the disease, blessed. Somewhere, sometime, you have benefited from the kindness, professionalism, and genuine concern of a medical professional, be it a nurse, pharmacist, dietitian, physician, therapist, or supporting staff.
Francisco Zepeda is a 54-year-old native of El Salvador who owns an insurance agency in San Francisco. Type 2 diabetes runs in his family. He says, "My grandmother lived with diabetes for about 30 years, and my father has it as well. I heard about diabetes all that time, but I never thought that it was going to happen to me. And I still hope that I'm not really diabetic. They say that once your blood sugar goes up, then you are diabetic, but I don't want to believe that I'm diabetic, you know what I mean?"
Your young primary care doctor may not know a lot about diabetes, according to a study led by Stephen Sisson, MD, of the Johns Hopkins School of Medicine. "When I graduated from residency here, I knew much more about how to ventilate a patient on a machine than how to control somebody's blood sugar, and that's a problem," said Sisson in a press release. "The average resident doesn't know what the goal for normal fasting blood sugar should be. If you don't know what it has to be, how are you going to guide your diabetes management with patients?"
UCSF will launch one of the nation's first inter-professional, team-based simulation learning centers to prepare doctors, nurses, pharmacists and dentists together for the changing health care landscape.
New technology is popping up all over in the medical community, from new diagnostic machines, to new ways of administering drugs, to an almost endless supply of self-monitoring devices such as blood glucose meters. But a technology often overlooked is one that could have the most impact-electronic medical records.
Novo Nordisk announced today the availability of NovoDoseTM - the first-ever mobile insulin dosing guide for physicians to look up dosing guidelines and blood glucose goals for their patients with diabetes, a disease that affects nearly 24 million Americans. The guide is available as an application on iTunes and is specific to Novo Nordisk's modern insulin analog portfolio: Levemir® (insulin detemir [rDNA origin] injection), NovoLog® (insulin aspart [rDNA origin] injection), and NovoLog® Mix 70/30 (70% insulin aspart protamine suspension and 30% insulin aspart injection, [rDNA origin]).
A week of Spanish study (5 days of classes) concentrated on your professional specialty. You will have 30 contact classroom hours, as well as opportunities outside the classroom for use of your Spanish. This course may qualify for continuing education units. Information on this is being developed. The course is arranged through Language Link, the U.S. Office for the Spanish Language Institute (800.552.2051, email@example.com), and is sponsored by the AADE California coordinating body.
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.